Company intelligence / Profile preview
Abogen Bioscience
- Ownership
- Private
- Employees
- ~300
- Development stage
- Other
Overview
Abogen Bioscience is a clinical-stage biotechnology company specializing in the development of mRNA-based therapeutics and vaccines. Founded in 2019 and headquartered in Suzhou, China, the company utilizes a proprietary lipid nanoparticle (LNP) delivery platform to create treatments for infectious diseases, oncology, and rare diseases. Its most prominent program is AWcorna (ARCoV), an mRNA COVID-19 vaccine developed in collaboration with Walvax Biotechnology and the Academy of Military Medical Sciences. Abogen has raised significant capital from global investors to scale its R&D pipeline and establish large-scale GMP manufacturing capabilities. The company's technology focuses on enhancing mRNA stability and delivery efficiency to improve therapeutic outcomes.
- Therapeutic areas
- Infectious DiseasesOncology
- Modalities
- mRNA-based drugsVaccineBiologicLipid nanoparticle delivery therapy
- Industry
- Biotech
Drug pipeline
16 assets15 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Abogen Bioscience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Abogen Bioscience.